Thrombolytic therapy of acute central retinal artery occlusion
Authors:
O. Dostál; Z. Dubská; L. Skalická; D. Karetová; Z. Kovařík; J. Dvořák; A. Linhart; B. Kalvodová
Published in:
Kardiol Rev Int Med 2010, 12(4): 175-178
Category:
Angiological Symposium
Overview
Arteria centralis retinae is the main retinal supply artery and is an ending branch of arteria ophthalmica. Acute ischemia of the retina, papilloedema and retinal cell necrosis develop in patients in whom a thrombus or embolus occlude this artery. Early diagnosis and treatment are crucial for restitution of the ocular function and maintenance of patient's quality of life. Modern fibrinolytic and endovascular therapy provides a very good treatment approach for patients with this disorder. The aim of the present paper is to compare conservative therapy and modern treatment based on own experiences.
Keywords:
a. centralis retinae – thrombolytic therapy – visual acuity
Sources
1. Von Graefe A. Embolie der arteria centralis retinae als Urscahe plotzlicher Erblingdung. Arch Ophtalmol 1859; 5: 136–157.
2. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophtalmol 1999; 128: 733–738.
3. Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophtalmology 1995; 102: 2029–2034.
4. Perkins SA, Magargal LE, Augsburger JJ et al. The idling retina – reversible visual loss in central retinal artery obstruction. Ann Ophtalmol 1987; 19: 3–6.
5. Arnold M, Koerner U, Remonda L et al. Comparsion of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry 2005: 76: 196–199.
6. Biousse V, Calvetti O, Bruce BB et al. Thrombolysis for acute central retinal occlusion. J Neuro Ophthalmol 2007; 27: 215–230.
7. Elikowski W, Grzybowski A, Małek M et al. Central retinal artery occlusion in a 21-year-old male amateur bodybuilder. Pol Merkur Lekarski 2010: 28: 462–465.
8. Ramezani A, Haghighatkhah H, Moghadasi H et al. A case of central retinal artery occlusion following embolization procedure for juvenile nasopharyngeal angiofibroma. Indian J Ophthalmol 2010; 58: 419–421.
9. Battaglia Parodi M, Iacono P, Cascavilla ML et al. Sequential anterior ischemic optic neuropaty and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema. Eur J Ophthalmol 2010; 20: 17.
10. Duker JS, Brown GC. Recovery following acute obstruction of the retinal and choroidal circulations. A case history. Retina 1988; 8: 257–260.
11. Hattenbach LO, Kuhli-Hattenbach C, Scharrer I et al. Intravenous Thrombolysis With Low-dose Recombinant Tissue Plasminogen Activator in Central Retinal Artery Occlusion. Am J Ophtalmol 2008; 146: 700–706.
12. Pettersen JA, Hill MD, Demchuk AM et al. Intra-arterial Trombolysis for Retinal Artery Occlusion: The Calgary Expirience. Can J Neurol Sci 2005; 32: 507–511.
13. Schumacher M, Schmidt D, Jurklies B et al. EAGLE--Study Group. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 2010; 117: 1367–1375.
14. Wolf A, Schumacher M, Neubauer AS et al. European Assessment Group for Lysis in the Eye Studien Gruppe. Comparsion of supraselective intrarterial fibrinolysis with conservative therapy: use in patients with acute non-arteritic central retinal artery occlusion. Opthalmology 2010; 107: 799-805.
15. Gryzska, Freitag J, Zeumer H. Selective cerebral intrarterial DSA. Complication rate and control of risk factors. Neuroradiology 1990; 32: 296–299.
16. Hattenbach LO, Friedrich Arndt C, Lerche R et al. Retinal Vein Occlusion and Low-dose Fibrinolytic Therapy (R.O.L.F): a prospective randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein oclussion. Retina 2009; 29: 932–940.
17. Vallée JN, Paques M, Aymard A et al. Combined central retinal arterial and venous obstruction: emergency opthalmic arterial fibrionylsis. Radiology 2002; 223: 351–359.
18. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thromolysis in treatment of central retinal artery occlusion. Arch Ophthalmol 2022; 120: 1234–1236.
19. Hazin R, Dixon JA, Bhatti MT. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Curr Opin Ophthalmol 2009; 20: 210–218.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2010 Issue 4
Most read in this issue
- Aortitis – an inflammation of the aortic wall
- Thrombolytic therapy of acute central retinal artery occlusion
- Rare popliteal artery diseases
- Small aneurysms of abdominal aorta – is it time to change our approach?